In various malignancies, P300 and CBP can acetylate multiple lysine residues on p53, and acetylated p53 significantly enhances DNA binding ability and transcriptional activity, thereby promoting tumour cell cycle arrest, senescence and apoptosis (Table 1). Here, TP53 is linked to neoplasm.